Search by Drug Name or NDC

    NDC 63323-0685-17 Posaconazole 18 mg/mL Details

    Posaconazole 18 mg/mL

    Posaconazole is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresensius Kabi USA, LLC. The primary component is POSACONAZOLE.

    Product Information

    NDC 63323-0685
    Product ID 63323-685_3ed81dc8-a1e0-4513-be2a-7a16aea62198
    Associated GPIs
    GCN Sequence Number 072141
    GCN Sequence Number Description posaconazole VIAL 300MG/16.7 INTRAVEN
    HIC3 W3B
    HIC3 Description ANTIFUNGAL AGENTS
    GCN 36248
    HICL Sequence Number 033461
    HICL Sequence Number Description POSACONAZOLE
    Brand/Generic Generic
    Proprietary Name Posaconazole
    Proprietary Name Suffix n/a
    Non-Proprietary Name Posaconazole
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 18
    Active Ingredient Units mg/mL
    Substance Name POSACONAZOLE
    Labeler Name Fresensius Kabi USA, LLC
    Pharmaceutical Class Azole Antifungal [EPC], Azoles [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA209983
    Listing Certified Through 2025-12-31

    Package

    NDC 63323-0685-17 (63323068517)

    NDC Package Code 63323-685-17
    Billing NDC 63323068517
    Package 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-685-17) / 16.7 mL in 1 VIAL, SINGLE-DOSE
    Marketing Start Date 2023-12-26
    NDC Exclude Flag N
    Pricing Information N/A